IVIg Intravenous Immuno Globulin Treatment Report
See also: Gammaglobulin (IVIg)
What is IVIg Intravenous Immuno Globulin?
Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immune disorders including myaesthenia gravis and multifocial motor neuropathy. It is sometimes trialed on ALS patients during the diagnostic process to rule out other illnesses.
Read more...
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Myasthenia Gravis | 1 | 0 |
Mouse over the table for more information
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Course of treatment ended
|
1 | 100% |
|
See all 1 patient who’ve stopped taking IVIg Intravenous Immuno Globulin
Stopped Taking IVIg Intravenous Immuno Globulin
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.